Potential Association between Vaginal Microbiota and Cervical Carcinogenesis in Korean Women: A Cohort Study
- PMID: 33572693
- PMCID: PMC7912413
- DOI: 10.3390/microorganisms9020294
Potential Association between Vaginal Microbiota and Cervical Carcinogenesis in Korean Women: A Cohort Study
Abstract
Convincing studies demonstrated that vaginal flora is one of the most impactful key components for the well-being of the genital tract in women. Nevertheless, the potential capability of vaginal-derived bacterial communities as biomarkers to monitor cervical carcinogenesis (CC) has yet to be studied actively compared to those of bacterial vaginosis (BV). We hypothesized that vaginal microbiota might be associated with the progression of CC. In this study, we enrolled 23 participants, including healthy controls (HC group; n = 7), patients with cervical intraepithelial neoplasia (CIN) 2 and 3 (CIN group, n = 8), and patients with invasive cervical cancer (CAN group; n = 8). Amplicon sequencing was performed using the Ion Torrent PGM to characterize the vaginal microbiota. Patients with CIN and CAN presented vaginal microbiota dysbiosis compared with HC. The alpha diversity analysis revealed that CC has a trend to be increased in terms of diversity indexes. Moreover, CC was associated with the abundance of specific microbes, of which Lactobacillus and Gardnerella were the most significantly different between HC and CIN, whereas Streptococcus was differentially abundant in CAN compared with CIN. We then evaluated their diagnostic abilities. Testing in terms of diagnostic ability using the three genera revealed considerably high performance with an area under the receiver-operating characteristic curve of 0.982, 0.953, and 0.922. The current study suggests that the presence of Gardnerella and Streptococcus may be involved in the advancment of CC.
Keywords: CIN prediction; CIN severity; vaginal microbiome; vaginosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.J Med Virol. 2023 Mar;95(3):e28595. doi: 10.1002/jmv.28595. J Med Virol. 2023. PMID: 36811337
-
Dysbiosis of Cervical and Vaginal Microbiota Associated With Cervical Intraepithelial Neoplasia.Front Cell Infect Microbiol. 2022 Feb 14;12:767693. doi: 10.3389/fcimb.2022.767693. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35237529 Free PMC article.
-
Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections.Front Cell Infect Microbiol. 2022 Jan 12;11:760459. doi: 10.3389/fcimb.2021.760459. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35096634 Free PMC article.
-
The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions.J Low Genit Tract Dis. 2022 Jan 1;26(1):79-84. doi: 10.1097/LGT.0000000000000644. J Low Genit Tract Dis. 2022. PMID: 34928257 Free PMC article. Review.
-
Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.Front Cell Infect Microbiol. 2020 Jan 10;9:452. doi: 10.3389/fcimb.2019.00452. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 31998661 Free PMC article. Review.
Cited by
-
Vaginal and tumor microbiomes in gynecological cancer (Review).Oncol Lett. 2023 Mar 3;25(4):153. doi: 10.3892/ol.2023.13739. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36936020 Free PMC article. Review.
-
Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions.J Adv Res. 2025 Aug;74:391-402. doi: 10.1016/j.jare.2024.09.009. Epub 2024 Sep 12. J Adv Res. 2025. PMID: 39260797 Free PMC article. Review.
-
Updates on Group B Streptococcus Infection in the Field of Obstetrics and Gynecology.Microorganisms. 2022 Dec 2;10(12):2398. doi: 10.3390/microorganisms10122398. Microorganisms. 2022. PMID: 36557651 Free PMC article. Review.
-
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.Protein Cell. 2024 Apr 1;15(4):239-260. doi: 10.1093/procel/pwad052. Protein Cell. 2024. PMID: 37946397 Free PMC article. Review.
-
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.Infect Agent Cancer. 2024 Apr 19;19(1):13. doi: 10.1186/s13027-024-00573-8. Infect Agent Cancer. 2024. PMID: 38641803 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources